Questcor Pharmaceuticals (QCOR)
This is a biopharmaceutical company. Questcor primary product is H.P. Acthar Gel (repository corticotropin injection) (Acthar), an injectable drug that is approved by the U.S. The stock is trading up 1.9% at $37.18 in recent trading.Today's Volume: 3,303,000 Average Volume: 1,537,400 Volume % Change: 356% From a technical standpoint, QCOR is gapping up today on heavy volume following the stock's recently collapse from $44 to $33 in just a few days. At last check, QCOR has pulled back significantly off its daily highs of near $40. Traders should now look to get long QCOR on its next high-volume move over $40, or get short below $33.66. Look for volume on either move that's near or well above 1.53 million shares.